News

An oral vaccine against recurrent UTIs could reduce the need for antibiotic treatment.

Fecal microbiota transplantation improves motor symptoms in Parkinson’s disease patients after 12 months. That's according to data from the GUT-PARFECT trial that recruited 46 Parkinson's disease patient.

A study has found older adults’ weaker immune response can be attributed to their relative deficiency in a specific type of T cell. This deficiency has been shown to account for poorer vaccination responses in the older population.

Mayo Clinic scientists have developed an immunotherapy strategy that utilizes CAR-MSCs. The approach shows potential in targeting inflammatory disease sites more precisely and improving immunosuppression and healing outcomes.

Engineering a virus that infects a frog-killing fungus could be the answer to controlling the spread of disease and saving the amphibians.

Scripps Research chemical biologists have developed a vaccine to block the effects of xylazine’s toxicity. The vaccine works by training the immune system to attack the drug, which is described in a new paper published in Chemical Communications.

Researchers have found a different and promising way to remove the noxious amyloid plaques in Alzheimer's disease: by directly mobilizing immune cells to consume them.

A second-generation melanoma vaccine improves long-term survival, particularly for men, a new study shows.

The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; however, annually updating those boosters for specific SARS-CoV-2 variants is inefficient for scientists and patients.

CCHFV poses a threat to U.S. military personnel and hospital staff as well as residents of a growing number of countries, says UC Riverside biomedical scientist.